Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;6(4):225-231.
doi: 10.1530/EC-17-0045. Epub 2017 Apr 5.

A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D)

Affiliations

A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D)

R Perchard et al. Endocr Connect. 2017 May.

Abstract

Background: Higher 25(OH)D3 levels are associated with lower HbA1c, but there are limited UK interventional trials assessing the effect of cholecalciferol on HbA1c.

Aims: (1) To assess the baseline 25(OH)D3 status in a Manchester cohort of children with type 1 diabetes (T1D). (2) To determine the effect of cholecalciferol administration on HbA1c.

Methods: Children with T1D attending routine clinic appointments over three months in late winter/early spring had blood samples taken with consent. Participants with a 25(OH)D3 level <50 nmol/L were treated with a one-off cholecalciferol dose of 100,000 (2-10 years) or 160,000 (>10 years) units. HbA1c levels before and after treatment were recorded.

Results: Vitamin D levels were obtained from 51 children. 35 were Caucasian, 11 South Asian and 5 from other ethnic groups. 42 were vitamin D deficient, but 2 were excluded from the analysis. All South Asian children were vitamin D deficient, with mean 25(OH)D3 of 28 nmol/L. In Caucasians, there was a negative relationship between baseline 25(OH)D3 level and HbA1c (r = -0.484, P < 0.01). In treated participants, there was no significant difference in mean HbA1c at 3 months (t = 1.010, P = 0.328) or at 1 year (t = -1.173, P = 0.248) before and after treatment. One-way ANCOVA, controlling for age, gender, ethnicity, BMI and diabetes duration showed no difference in Δ HbA1c level.

Conclusion: We report important findings at baseline, but in children treated with a stat dose of cholecalciferol, there was no effect on HbA1c. Further studies with larger sample sizes and using maintenance therapy are required.

Keywords: HbA1c; bone; diabetes; paediatric endocrinology; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram to show the recruitment of patients with T1D from the clinic.
Figure 2
Figure 2
Changes in HbA1c levels over time after treatment with cholecalciferol.

References

    1. Diabetes UK. In Diabetes in the UK 2010: Key Statistics on Diabetes. March 2010. London, UK: Diabetes UK, 2010. (available at: https://www.diabetes.org.uk/documents/reports/diabetes_in_the_uk_2010.pdf)
    1. Royal College of Paediatrics and Child Health, National Paediatric Diabetes Audit. In National Paediatric Diabetes Audit Report 2013–14, Part 1: Care Processes and Outcomes. London, UK: RCPCH, 2015. (available at: http://www.rcpch.ac.uk/system/files/protected/page/Revised%20Sept%202014...)
    1. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, et al. Global consensus recommendations on prevention and management of nutritional rickets. Journal of Clinical Endocrinology & Metabolism 2016. 101 394–415. - PMC - PubMed
    1. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, et al. Global consensus recommendations on prevention and management of nutritional rickets. Hormone Research in Paediatrics 2016. 85 83–106. (10.1159/000443136) - DOI - PubMed
    1. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology & Metabolism 2011. 96 53–58. - PMC - PubMed

LinkOut - more resources